DR. BRETT HOWARD HERZOG MD PHD NPI 1023499282

NPI Information

  • NPI: 1023499282
  • Provider Name: DR. BRETT HOWARD HERZOG, MD PHD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1418 CROSS ST
    DIV IM MEDICAL ONCOLOGY, STE 180
    SHILOH, IL
    ZIP 62269
  • Phone: (618) 607-1340

Map and Directions

Get Directions

NPI Details

DR. Brett Howard Herzog, MD PHD is a medical oncology internal medicine in Shiloh, IL with 10 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Brett Howard Herzog, MD PHD NPI is 1023499282. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:2015

The provider's business location address is:

1418 CROSS ST
DIV IM MEDICAL ONCOLOGY, STE 180
SHILOH, IL
ZIP 62269-914
Phone: (618) 607-1340
Fax: (618) 622-9724

The NPI 1023499282 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, durvalumab, 10 mg (HCPCS:J9173)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Transfusion of blood or blood products (HCPCS:36430)
  • Red blood cells, leukocytes reduced, each unit (HCPCS:P9016)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 6/13/2015 and was last updated on 11/8/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine036153509ILLINOISNo
2207RX0202XInternal MedicineMedical Oncology036153509ILLINOISYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1200063716MEDICAIDMISSOURI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.